Question 1

What specific chemotherapy will I receive in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy clinical trial (NCT01019616). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this new treatment compare to my previous chemotherapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy clinical trial (NCT01019616). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy clinical trial (NCT01019616). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatments and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy clinical trial (NCT01019616). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy clinical trial (NCT01019616). Contact the study team or your healthcare provider for specific answers.

Question 6

How will this trial fit into my overall treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy clinical trial (NCT01019616). Contact the study team or your healthcare provider for specific answers.

What this study is about